PlainPharmaWatch

CMS Open Payments · Program Year 2024

Georgia

Georgia received $107,069,457.50 in pharmaceutical-industry payments to 22,488 physicians and 29 teaching hospitals across 601,420 transactions.

$107.1M
Total payments
$86.8M
To physicians
$10.0M
To teaching hospitals
#10
of 59 states

In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $107.1M in payments to 22,488 physicians and 29 teaching hospitals in Georgia. That ranks Georgia #10 of 59 states and territories (0.8% of the US total), averaging $3.9K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

The verdict

Georgia pairs top-quartile payment volume with a physician-heavy payment mix.

#10
of 59 states
0.8%
of the national total
81.1%
to physicians vs. hospitals
22,488
physicians paid

What the Data Shows for Georgia

Georgia sits in the high-volume tercile at #10 of 59 by all-tracks dollars (0.8% of the US total): $107,069,457.50 across 601,420 PY2024 transactions.

Physician versus hospital mix is near the corpus middle (81.1% / 9.3%). Average transaction $178.03. Leading nature of payment: "Acquisitions" at $26.9M (25.1% of the state file; top-three natures 56.4%).

Georgia sits in the 85th percentile (top-10 nationally). Just above: Ohio ($112.1M). Just below: Michigan ($101.8M). For context: top-ranked California ($342.4M) is 3.2× larger than Georgia. CMS Sunshine Act framework and methodology.

Physician vs Hospital Payments

How pharmaceutical payments in Georgia are distributed between physicians and teaching hospitals.

Physician Payments

$86.8M

81.1% of total · 22,488 recipients · $3.9K avg

Teaching Hospital Payments

$10.0M

9.3% of total · 29 hospitals · $344.1K avg

Payment Breakdown by Type

Georgia has 16 types of pharmaceutical payments. "Acquisitions" accounts for 25.1%.

Nature concentration in Georgia

Top three Open Payments natures are 56.4% of state dollars; residual is every other reported nature

Acquisitions$26.9MCompensation for Services Ot…$18.0MRoyalty or License$15.5MAll other natures (13)$46.7M

Payment categories in Georgia

Top categories by total reported dollar volume

1. Acquisitions$26.9M2. Compensation for Services…$18.0M3. Royalty or License$15.5M4. Food and Beverage$15.0M5. Consulting Fee$12.6M6. Grant$6.6M7. Travel and Lodging$5.7M8. Education$2.4M9. Honoraria$1.0M10. Compensation for Faculty…$937.7K
Payment Type Amount Transactions
Acquisitions $26.9M 11
Compensation for Services Other Than Consulting $18.0M 6,971
Royalty or License $15.5M 605
Food and Beverage $15.0M 560,962
Consulting Fee $12.6M 5,376
Grant $6.6M 200
Travel and Lodging $5.7M 17,454
Education $2.4M 6,670
Honoraria $1.0M 443
Compensation for Faculty or Speaker (Medical Education) $937.7K 502
Long-Term Medical Supply or Device Loan $817.0K 730
Space Rental or Facility Fees $793.8K 181
Debt Forgiveness $500.6K 127
Charitable Contribution $197.1K 5
Gift $131.3K 892
Entertainment $17.3K 291

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024

What Georgia totals can and cannot tell you

The aggregate payment figure for Georgia measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.

Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.

View saved (states)
Download Georgia's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.